Summaries for patients. Promising therapy for bone marrow failure from myelodysplastic syndromes.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000753:Anemia, Refractory / Q000188:drug therapy / Q000209:etiology; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001853:Bone Marrow / Q000503:physiopathology*; D018450:Disease Progression; D017707:Erythrocyte Transfusion; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000503:physiopathology*; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology; D016019:Survival Analysis; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents